Biodexa Pharmaceuticals（BDRX.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他82.85%
对冲基金16.20%
机构投资者0.62%
个人与内部人士0.33%
其他0.00%

主要股东

主要股东最新
股东
Armistice Capital LLC	9.99%	8.28 万	6.98%	+6.33 万	2026/07/15
Sabby Management, LLC	6.21%	5.15 万	2.23%	+1.34 万	2026/03/31
Brio Capital L.P.	0.40%	3,354.00	0.34%	+0	2024/11/14
Simon TurtonSenior Independent Non-Executive Director	0.33%	2,765.00	0.28%	+0	2026/03/12
GAMMA Investing LLC	0.15%	1,203.00	0.28%	-1,553.00	2026/06/30
Allied Private Wealth	0.06%	489.00	--	+489.00	2026/06/30
SBI Holdings, Inc.	<0.01%	29.00	<0.01%	-1.00	2026/06/30
UBS Asset Management AG	<0.01%	25.00	0.09%	-395.00	2026/03/31
Hilton Head Capital Partners, LLC	<0.01%	6.00	<0.01%	+0	2026/06/30
Rhumbline Advisers Ltd Partnership	<0.01%	3.00	<0.01%	-1.00	2026/03/31
Caitong International Asset Management Co., Limited	<0.01%	1.00	--	+1.00	2026/03/31
Fiona SharpCompany Secretary, CFO & Director	0.00%	0.00	--	+0	2026/03/12
Melior Pharmaceuticals, Inc	0.00%	0.00	0.06%	-284.00	2026/03/12
GS Capital Partners LLC	0.00%	0.00	0.06%	-288.00	2026/03/12
Stephen StampCEO & Director	0.00%	0.00	0.00%	+0	2026/03/12
Stephen ParkerIndependent Non-Executive Chairman	0.00%	0.00	0.00%	+0	2026/03/12
Hudson River Trading LLC	0.00%	0.00	0.47%	-2,116.00	2026/03/31
Ann MerchantIndependent Non-Executive Director	0.00%	0.00	0.00%	+0	2026/03/12
Sijmen de VriesIndependent Non-Executive Director	0.00%	0.00	0.00%	+0	2026/03/12
Bukwang Pharmaceutical Co., Ltd.	0.00%	0.00	0.06%	-284.00	2026/03/12